ISRCTN99601810已完成未知
Clinical stUdy to assess the Glycaemic Effect of Reducose on a Sucrose challenge (SUGERS): a double blind, placebo controlled, crossover study
Phynova Group Limited0 个研究点目标入组 40 人开始时间: 2020年10月23日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33858439/ (added 13/08/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Consent to study protocol
- •2. Aged 18-60 years
- •3. BMI 20-29.9 kg/m²
- •4. Fasting blood glucose <6.1 mmol/l
排除标准
- •1. Pregnant or lactating
- •2. Any known food allergies or intolerance to mulberry leaf extracts
- •3. Presence of a medical condition, or taking medication known to affect glucose regulation and/or influence digestion and absorption of nutrients
- •4. History of diabetes mellitus (type I or type II), or the use of antihyperglycaemic drugs or insulin to treat diabetes or related conditions
- •5. Use of steroids, protease inhibitors, or antipsychotics which would affect glucose metabolism and body fat distribution
研究者
相似试验
已完成
2 期
Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized LipodystrophyGeneralized LipodystrophyNCT04159415Regeneron Pharmaceuticals16
已完成
不适用
Determining the amount of time with low glucose in people using premixed (biphasic) insuliISRCTN10603608Abbott Diabetes Care Ltd43
已完成
1 期
The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male ParticipantsHealthy VolunteersNCT01606423Eli Lilly and Company21
已完成
1 期
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin PumpDiabetes Mellitus, Type 1NCT03056456Eli Lilly and Company24
已完成
2 期
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesType 2 Diabetes MellitusNCT00382239AstraZeneca153